Related Experiment Video
Updated: Jan 3, 2026

Author Spotlight: Investigating the Pathophysiology of Eosinophilic Esophagitis
Published on: May 10, 2024
Practical Approach to Children Presenting with Eosinophila and Hypereosinophilia
Giorgio Costagliola1, Serena Di Marco1, Pasquale Comberiati1
1Section of Paediatrics, Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy.
Insights
Peripheral eosinophilia, a blood eosinophil count over 500 cells/μL, requires careful diagnosis. This review proposes a diagnostic algorithm for children with eosinophilia or hypereosinophilia, focusing on clinical history and eosinophil levels.
Area of Science:
- Hematology
- Clinical Immunology
- Pediatric Medicine
Background:
- Peripheral eosinophilia, defined as a blood eosinophil count > 500 cells/μL, is a common clinical finding presenting diagnostic challenges.
- Eosinophilia is classified into mild, moderate, and severe categories, with hypereosinophilia defined by counts >1500 cells/μL on serial testing.
- Common causes include allergic disorders, parasitic infections, hematologic malignancies, and vasculitis, with allergic and parasitic causes being most frequent.
Purpose of the Study:
- To present a diagnostic algorithm for evaluating pediatric patients with blood eosinophilia or hypereosinophilia.
- To guide clinicians in identifying patients requiring further investigation based on clinical presentation and eosinophil levels.
Main Methods:
- The proposed algorithm prioritizes patient history and clinical manifestations.
- It utilizes the level and persistence of blood eosinophil counts as secondary diagnostic criteria.
- The algorithm aims to streamline the diagnostic process for pediatric eosinophilia.
Main Results:
- Allergic disorders typically correlate with mild eosinophilia, while counts >20,000 cells/μL suggest myeloproliferative disorders.
- Eosinophils can cause organ damage (cardiac, pulmonary, cutaneous) through mediator release.
- The algorithm facilitates the identification of patients needing advanced laboratory or instrumental evaluations.
Conclusions:
- A systematic approach integrating clinical data and eosinophil quantification is crucial for diagnosing pediatric eosinophilia.
- The proposed algorithm aids in differentiating benign causes from serious conditions and assessing organ involvement.
- Effective management of eosinophilia relies on accurate etiologic diagnosis and prompt investigation of potential organ damage.
Abstract:
Eosinophilia is not a rare finding in clinical practice, and often poses problems in terms of etiologic research and differential diagnosis. Peripheral eosinophilia is defined by a blood eosinophil count > 500 cells/μL. It is classified into mild (500-1500 cells/μl), moderate (1500-5000 cells/μl) and severe for an eosinophil count > 5000 cells /μl. The term "hypereosinophilia" defines a condition characterized by a blood eosinophil count >1500 cells/μl in at least two consecutive tests made with a minimum of a 4-week interval. The causes of eosinophilia are various, and can be summarized by the acronym "APLV" which refers to Allergic disorders, Parasitic infections, Leukemia/ Lymphomas (and solid tumors) and Vasculitis-Immunodeficiency diseases, with allergic disorders and parasitic infections representing the most commonly identified causes. Allergic disorders are usually associated with mild eosinophilia, whereas values >20.000 cell/μl are highly suggestive for myeloproliferative disorders. Eosinophils may also be directly responsible for organ damage, mainly at cardiac, pulmonary and cutaneous level, deriving from the release of the granule products, of lipidic mediators and cytokines. Therefore, in the physician's approach to a patient with persistent hypereosinophilia, it is also important to investigate the presence of organ involvement. In this review, we propose a diagnostic algorithm for children presenting with either blood eosinophilia or hypereosinophilia. This algorithm focuses on the patient's history and clinical manifestations as the first step and the level and persistence of blood eosinophilia as the second, and this can help the physician to identify patients presenting with an elevated blood eosinophil count that need further laboratory or instrumental investigations.
Related Concept Videos
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Allergic Reactions
Asthma-I: Introduction
Barrett Esophagus-II: Clinical Manifestations and Management
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.

